US4447A - Car- wheel - Google Patents

Car- wheel Download PDF

Info

Publication number
US4447A
US4447A US4447DA US4447A US 4447 A US4447 A US 4447A US 4447D A US4447D A US 4447DA US 4447 A US4447 A US 4447A
Authority
US
United States
Prior art keywords
rim
center
groove
wheel
wedge
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
Publication date
Application granted granted Critical
Publication of US4447A publication Critical patent/US4447A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B60VEHICLES IN GENERAL
    • B60BVEHICLE WHEELS; CASTORS; AXLES FOR WHEELS OR CASTORS; INCREASING WHEEL ADHESION
    • B60B17/00Wheels characterised by rail-engaging elements
    • B60B17/0055Wheels characterised by rail-engaging elements with non-elastic tyres (e.g. of particular profile or composition)

Definitions

  • (Fig. 1) the dotted line (0) and the inside line (6) representing the slope of the inside face of the rim (A, A,) in which the sloping surface of the center (N, N,) has to be fitted, as shown at (w, 00, Fig. 3), and at the rim by (w w, a? m Fig. 4).
  • the lines (6, cl) represent the slope of the tread of the wheel and (f,) the flange, Figs. 1 and 4).
  • the rim (A, A,) has in the middle of the inside slope (c b) a groove, all around, as shown.
  • FIG. 4 at (4, 3).
  • This groove is beveled from the flange side, but the other side, being parallel with the face of the wheel,the depth of said beveled groove is about one half its width,the groove and the shape of the same is shown (Fig. 4 at 4, 3, u, 4, 3, u,) (e, (Z) the said tread of the wheel, and (f) the flange.
  • Fig. 2 (N, N).
  • the center of the wheel being solid (and fixed and connected, as commonly with the spokes and hub) not shown in the drawings.
  • the outside face (m, Z) of said center is also sloping in the same degree as the slope of the rim (A A) before described, and has to fit into the inside face (a, b) Fig. 1, as illustrated (Fig. 3) by the dotted lines (as, w to m w Fig. 4).
  • In the middle of the outside face (Z, m) of the center (N, N) is also a groove (0) corresponding with the groove of the inside of the rim (A, A) (4, 3, Fig.
  • Fig. 5 represents the circular wedge, divided in three parts (2%, t, t) beveled on one corner of its periphery as it is shown in Fig. 7, at 8,)said bevel has to fit against the bevel of the rim-groove (4, 3, Fig. 4).
  • Fig. 6 showing the draw-wedge (s) and (g) the screw and nut of the same (the said drawwedge is not represented in the model).
  • Fig. 4 represents the rim (A, A,) the center (N, N,) and circular-wedge (t, t, 25,)
  • the center (N, N,) being narrower than the rim (A, A,) being made flush with the rim (A, A,) from the flange side, but recedes from the other about one inch; (t, 25,) showing the circular wedge when forced out from the center into the groove (4, 3, 4, 3) of the rim (A) at Fig. 3.
  • the center (N, N,) is represented as being withdrawn from the rim (A, A,) for better illustration, the circular wedge (23, t, t,) represented in the posi-' tion ready to be fitted into the rim A A other parts are already described.

Description

CONNECTING RIM 0R CIRCULAR WEDGE FOR DRAWING ON AND FASTENING WROUGHT 0B. CAST IRON RIM$ 0N RAILROAD WHEELS. No. 4,447. I Patented Apr. 4, 1846.
UNITED STATES PATENT OFFICE.
THOMAS GLASCO, OF WILMINGTON, DELAWARE.
GAR-WHEEL.
Specification of Letters Patent No. 4,447, dated April 4, 1846.
To all whom it may concern Be it known that I, THOMAS GLASCO, of Wilmington, in the county of Newcastle and State of Delaware, have invented a new and Improved Mode of Fastening and Connecting Rims and Centers on Railroad-Wheels; and I do hereby declare that the following is a full and exact description, reference being had to the annexed drawings, making a part of this specification, in which- Fig. 1, (A, A,) represents-the rim of a common railroad wheel; Fig. 2, (N, N,) the center of the wheel, to fit into the rim (A, A); Fig. 3, a cross section of the center (N, N) Fig. 4, a cross section of the wheel (A, A) in connection with the rim (A), center (N, N), and circular wedge (t, t, t) Fig. 5, the circular wedge (t, t, t) Fig. 6, the draw-wedge on a larger scale, and Fig. 7, profile section of a part of the circular wedge.
In (Fig. 1,) the dotted line (0) and the inside line (6) representing the slope of the inside face of the rim (A, A,) in which the sloping surface of the center (N, N,) has to be fitted, as shown at (w, 00, Fig. 3), and at the rim by (w w, a? m Fig. 4). The lines (6, cl) represent the slope of the tread of the wheel and (f,) the flange, Figs. 1 and 4). The rim (A, A,) has in the middle of the inside slope (c b) a groove, all around, as shown.
(Fig. 4) at (4, 3). This groove is beveled from the flange side, but the other side, being parallel with the face of the wheel,the depth of said beveled groove is about one half its width,the groove and the shape of the same is shown (Fig. 4 at 4, 3, u, 4, 3, u,) (e, (Z) the said tread of the wheel, and (f) the flange.
Fig. 2, (N, N). The center of the wheel being solid (and fixed and connected, as commonly with the spokes and hub) not shown in the drawings. The outside face (m, Z) of said center (near the rim) is also sloping in the same degree as the slope of the rim (A A) before described, and has to fit into the inside face (a, b) Fig. 1, as illustrated (Fig. 3) by the dotted lines (as, w to m w Fig. 4). In the middle of the outside face (Z, m) of the center (N, N) is also a groove (0) corresponding with the groove of the inside of the rim (A, A) (4, 3, Fig. 4,) but so deep is the groove in the center as to receive in it the whole body of the circular wedge (t, t, t, Fig. 5,) as shown (Fig. 2) by a red line (0) dotted line (72, n, m) the depth of the groove, and the letters (If, t, t,) the three divisions of the circular wedge. (12, p, p, &c.) are screws, with followers (9 g g) and heads (0 r, 1', &c.) These screws are for the purpose set into the inner side of the center wheels, between the spokes, to force the circular wedge (t, t t) outward from the center groove (2 a, Fig. 3) into the opposite groove (4, 3) of the rim (A, A,) Fig. 4. The draw-wedges (8) may be used for the same purpose as the screws before mentioned when desired.
Fig. 5 represents the circular wedge, divided in three parts (2%, t, t) beveled on one corner of its periphery as it is shown in Fig. 7, at 8,)said bevel has to fit against the bevel of the rim-groove (4, 3, Fig. 4). Fig. 6 showing the draw-wedge (s) and (g) the screw and nut of the same (the said drawwedge is not represented in the model).
Fig. 4 represents the rim (A, A,) the center (N, N,) and circular-wedge (t, t, 25,)
united andshown in a sectional view; (a, a, a, and 4, 34, 3) the bevel of the wedge (t, t, t,) and rim (A, A,) showing in same time the joining of the bevels, and the manner of forcing by said bevels, the center (N, N) into the rim (A, A,) (p, a, 0",) the screw-and (s) the draw-wedge. The center (N, N,) being narrower than the rim (A, A,) being made flush with the rim (A, A,) from the flange side, but recedes from the other about one inch; (t, 25,) showing the circular wedge when forced out from the center into the groove (4, 3, 4, 3) of the rim (A) at Fig. 3. The center (N, N,) is represented as being withdrawn from the rim (A, A,) for better illustration, the circular wedge (23, t, t,) represented in the posi-' tion ready to be fitted into the rim A A other parts are already described.
To put the center (N, N,) and the rim (A, A,) together, to make them permanently connected, it requires that the screws (p, p, p, &c.) should be drawn back, so that the circular wedge (25, t, t,) becomes flush with the sloping surface of the center (N, N,), as represented in the drawing, Fig. 3 at w w, x w), after which the center (N, N,) is to be inserted into the inside of the rim (A, A) (following the dotted lines a", m m The rivets p, p, p, &c.) (or the drawwedge s) are screwed forward by which the bevel of the circular wedge (If, t, t,) is forced and of the center and into the groove of the rim (A) meeting the bevel surface of the with the rim (A, A) by the circular wedge (which is divided in three parts, 25, t, t,) and fastening the same by the screws (10, p, p,
&c.), as described in the specification and illustrated by the annexed drawings.
THOMAS GLASCO.
Witnesses S. PRETIYMAN, P. S. J OI-INSON-
US4447D Car- wheel Expired - Lifetime US4447A (en)

Publications (1)

Publication Number Publication Date
US4447A true US4447A (en) 1846-04-04

Family

ID=2064748

Family Applications (1)

Application Number Title Priority Date Filing Date
US4447D Expired - Lifetime US4447A (en) Car- wheel

Country Status (1)

Country Link
US (1) US4447A (en)

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080051906A1 (en) * 2005-02-17 2008-02-28 Malandain Hugues F Percutaneous spinal implants and methods
WO2014153063A1 (en) 2013-03-14 2014-09-25 Amgen Inc. AGLYCOSYLATED Fc-CONTAINING POLYPEPTIDES
WO2014164981A1 (en) 2013-03-12 2014-10-09 The General Hospital Corporation Modified mullerian inhibiting substance (mis) proteins and uses thereof for the treatment of diseases
WO2015089321A2 (en) 2013-12-11 2015-06-18 The General Hospital Corporation Use of mullerian inhibiting substance (mis) proteins for contraception and ovarian reserve preservation
WO2016166360A1 (en) 2015-04-17 2016-10-20 Bayer Pharma Aktiengesellschaft Bispecific antibody constructs for cdh3 and cd3
EP3456743A1 (en) 2013-05-30 2019-03-20 Kiniksa Pharmaceuticals, Ltd. Oncostatin m receptor antigen binding proteins
WO2019070901A1 (en) 2017-10-04 2019-04-11 Amgen Inc. Transthyretin immunoglobulin fusions
WO2020025792A1 (en) 2018-08-03 2020-02-06 Amgen Research (Munich) Gmbh Antibody constructs for cldn18.2 and cd3
WO2020025596A1 (en) 2018-07-31 2020-02-06 Amgen Research (Munich) Gmbh Dosing regimen for bcma-cd3 bispecific antibodies
WO2020025532A1 (en) 2018-07-30 2020-02-06 Amgen Research (Munich) Gmbh Prolonged administration of a bispecific antibody construct binding to cd33 and cd3
WO2021007150A1 (en) 2019-07-08 2021-01-14 Amgen Inc. Multispecific transthyretin immunoglobulin fusions
WO2021030602A1 (en) 2019-08-13 2021-02-18 Amgen Inc. Interleukin-2 muteins for the expansion of t-regulatory cells
EP3819007A1 (en) 2019-11-11 2021-05-12 Amgen Research (Munich) GmbH Dosing regimen for anti-bcma agents
WO2021127262A1 (en) 2019-12-17 2021-06-24 Amgen Inc. Dual interleukin-2 /tnf receptor agonist for use in therapy
WO2021150824A1 (en) 2020-01-22 2021-07-29 Amgen Research (Munich) Gmbh Combinations of antibody constructs and inhibitors of cytokine release syndrome and uses thereof
EP3865514A1 (en) 2015-07-31 2021-08-18 Amgen Research (Munich) GmbH Bispecific antibody constructs binding dll3 and cd3
EP3912999A1 (en) 2015-07-31 2021-11-24 Amgen Research (Munich) GmbH Bispecific antibody constructs binding egfrviii and cd3
WO2021243320A2 (en) 2020-05-29 2021-12-02 Amgen Inc. Adverse effects-mitigating administration of a bispecific antibody construct binding to cd33 and cd3
WO2022103781A1 (en) 2020-11-10 2022-05-19 Amgen Inc. Methods for administering a bcma x cd3 binding molecule
WO2023079493A1 (en) 2021-11-03 2023-05-11 Affimed Gmbh Bispecific cd16a binders
WO2023078968A1 (en) 2021-11-03 2023-05-11 Affimed Gmbh Bispecific cd16a binders
EP4219562A2 (en) 2015-07-31 2023-08-02 Amgen Research (Munich) GmbH Antibody constructs for flt3 and cd3
EP4327885A2 (en) 2015-07-31 2024-02-28 Amgen Research (Munich) GmbH Antibody constructs for msln and cd3

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080051906A1 (en) * 2005-02-17 2008-02-28 Malandain Hugues F Percutaneous spinal implants and methods
WO2014164981A1 (en) 2013-03-12 2014-10-09 The General Hospital Corporation Modified mullerian inhibiting substance (mis) proteins and uses thereof for the treatment of diseases
WO2014153063A1 (en) 2013-03-14 2014-09-25 Amgen Inc. AGLYCOSYLATED Fc-CONTAINING POLYPEPTIDES
EP4349864A2 (en) 2013-05-30 2024-04-10 Kiniksa Pharmaceuticals, Ltd. Oncostatin m receptor antigen binding proteins
EP3971212A1 (en) 2013-05-30 2022-03-23 Kiniksa Pharmaceuticals, Ltd. Oncostatin m receptor antigen binding proteins
EP3456743A1 (en) 2013-05-30 2019-03-20 Kiniksa Pharmaceuticals, Ltd. Oncostatin m receptor antigen binding proteins
WO2015089321A2 (en) 2013-12-11 2015-06-18 The General Hospital Corporation Use of mullerian inhibiting substance (mis) proteins for contraception and ovarian reserve preservation
EP4008339A1 (en) 2013-12-11 2022-06-08 The General Hospital Corporation Use of mullerian inhibiting substance (mis) proteins for contraception
EP4276116A2 (en) 2015-04-17 2023-11-15 Amgen Research (Munich) GmbH Bispecific antibody constructs for cdh3 and cd3
WO2016166360A1 (en) 2015-04-17 2016-10-20 Bayer Pharma Aktiengesellschaft Bispecific antibody constructs for cdh3 and cd3
EP4327885A2 (en) 2015-07-31 2024-02-28 Amgen Research (Munich) GmbH Antibody constructs for msln and cd3
EP3912999A1 (en) 2015-07-31 2021-11-24 Amgen Research (Munich) GmbH Bispecific antibody constructs binding egfrviii and cd3
EP4219562A2 (en) 2015-07-31 2023-08-02 Amgen Research (Munich) GmbH Antibody constructs for flt3 and cd3
EP3865514A1 (en) 2015-07-31 2021-08-18 Amgen Research (Munich) GmbH Bispecific antibody constructs binding dll3 and cd3
WO2019070901A1 (en) 2017-10-04 2019-04-11 Amgen Inc. Transthyretin immunoglobulin fusions
WO2020025532A1 (en) 2018-07-30 2020-02-06 Amgen Research (Munich) Gmbh Prolonged administration of a bispecific antibody construct binding to cd33 and cd3
WO2020025596A1 (en) 2018-07-31 2020-02-06 Amgen Research (Munich) Gmbh Dosing regimen for bcma-cd3 bispecific antibodies
WO2020025792A1 (en) 2018-08-03 2020-02-06 Amgen Research (Munich) Gmbh Antibody constructs for cldn18.2 and cd3
WO2021007150A1 (en) 2019-07-08 2021-01-14 Amgen Inc. Multispecific transthyretin immunoglobulin fusions
WO2021030602A1 (en) 2019-08-13 2021-02-18 Amgen Inc. Interleukin-2 muteins for the expansion of t-regulatory cells
WO2021094000A1 (en) 2019-11-11 2021-05-20 Amgen Research (Munich) Gmbh Dosing regimen for anti-bcma agents
EP3819007A1 (en) 2019-11-11 2021-05-12 Amgen Research (Munich) GmbH Dosing regimen for anti-bcma agents
WO2021127262A1 (en) 2019-12-17 2021-06-24 Amgen Inc. Dual interleukin-2 /tnf receptor agonist for use in therapy
WO2021150824A1 (en) 2020-01-22 2021-07-29 Amgen Research (Munich) Gmbh Combinations of antibody constructs and inhibitors of cytokine release syndrome and uses thereof
WO2021243320A2 (en) 2020-05-29 2021-12-02 Amgen Inc. Adverse effects-mitigating administration of a bispecific antibody construct binding to cd33 and cd3
WO2022103781A1 (en) 2020-11-10 2022-05-19 Amgen Inc. Methods for administering a bcma x cd3 binding molecule
WO2023079493A1 (en) 2021-11-03 2023-05-11 Affimed Gmbh Bispecific cd16a binders
WO2023078968A1 (en) 2021-11-03 2023-05-11 Affimed Gmbh Bispecific cd16a binders

Similar Documents

Publication Publication Date Title
US4447A (en) Car- wheel
US62402A (en) Improvement in wheels foe vehicles
US118815A (en) Improvement in wagon-wheels
US1490444A (en) Disk-wheel hub fastening
US70438A (en) Improvement in securing the ends of fellies
US120720A (en) Improvement in carriage-wheels
US1359964A (en) Metal wheel
US238475A (en) allen
USRE19010E (en) Metal wheel
US1327310A (en) Wheel
US280063A (en) Thue j
US1941405A (en) Demountable rim wheel
US1563882A (en) Metal-felly wheel
US821658A (en) Tire-coupling.
US1473669A (en) Ply-wood wheel
US458992A (en) Metallic hub for vehicles
US604520A (en) Robert l
US3700A (en) Method of making cast-ikon railroad-car wheels
US296840A (en) Car-wheel
US1479373A (en) Car wheel
US283397A (en) William j
US657699A (en) Wheel.
US129655A (en) Improvement in railway car-wheels
US1578175A (en) Wheel
US1441768A (en) Fixed and demountable rim construction for automobile wheels